(Q45303980)

25 May 2018

title

Recombinant AAV Viral Vectors Serotype 1, 2, and 5 Mediate Differential Gene Transfer Efficiency in Rat Striatal Fetal Grafts (English)

1 reference

25 May 2018

1 reference

5

1 reference

18351017

17 March 2018

http://europepmc.org/abstract/MED/18351017

Liliane Tenenbaum

8

1 reference

18351017

17 March 2018

http://europepmc.org/abstract/MED/18351017

Marc Levivier

7

object named as

Marc Levivier

1 reference

25 May 2018

Jacques Brotchi

6

object named as

Jacques Brotchi

1 reference

25 May 2018

Olivier Bockstael

3

object named as

Olivier Bockstael

1 reference

25 May 2018

author name string

Alphonse Lubansu

1

1 reference

25 May 2018

Laurence Abeloos

2

1 reference

25 May 2018

Enni Lehtonen

4

1 reference

25 May 2018

publication date

1 November 2007

1 reference

25 May 2018

published in

Cell Transplantation

1 reference

25 May 2018

volume

16

1 reference

25 May 2018

issue

10

1 reference

25 May 2018

page(s)

1013-1020

1 reference

25 May 2018

Ciliary neurotrophic factor protects striatal output neurons in an animal model of Huntington disease

cites work

1 reference

https://api.crossref.org/works/10.3727%2F000000007783472372

Fetal neural grafts for Huntington's disease: a prospective view

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783472372

Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783472372

Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783472372

Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783472372

Recombinant adeno-associated viral vectors in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783472372

Identification of PDGFR as a receptor for AAV-5 transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783472372

Cell therapy in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783472372

Striatal neural grafting improves cortical metabolism in Huntington's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783472372

Bilateral human fetal striatal transplantation in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783472372

Dosage effects of riluzole in Huntington's disease: a multicenter placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783472372

Lentiviral vectors for use in the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783472372

AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783472372

AAV2 vectors mediate efficient and sustained transduction of rat embryonic ventral mesencephalon.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783472372

First step towards cell therapy for Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783472372

High-capacity, helper-dependent, "gutless" adenoviral vectors for gene transfer into brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783472372

Immune responses to AAV in a phase I study for Canavan disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783472372

Toxicity and tolerability of recombinant human ciliary neurotrophic factor in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783472372

Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783472372

Brain-derived neurotrophic factor inhibits apoptosis and dopamine-induced free radical production in striatal neurons but does not prevent cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783472372

Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783472372

Differential loss of striatal projection neurons in Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783472372

Evidence for neuronal degeneration and dendritic plasticity in cortical pyramidal neurons of Huntington's disease: a quantitative Golgi study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783472372

High-dose creatine therapy for Huntington disease: a 2-year clinical and MRS study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783472372

Efficient early and sustained transduction of human fetal mesencephalon using adeno-associated virus type 2 vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783472372

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783472372

Creatine supplementation in Huntington's disease: a placebo-controlled pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783472372

Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783472372

10.3727/000000007783472372

21 January 2018

Identifiers

DOI

1 reference

25 May 2018

1 reference

25 May 2018